Yu Zhang
- Pharmaceutical Science top 0.05%
- Advanced Drug Delivery Systems 80
- Drug Solubulity and Delivery Systems 69
- Biomaterials top 0.1%
- Nanoparticle-Based Drug Delivery 119
- Molecular Medicine top 0.5%
- Hydrogels: synthesis, properties, applications 21
- Immunology top 1%
- Immunotherapy and Immune Responses 46
- Biomedical Engineering top 0.5%
- Nanoplatforms for cancer theranostics 72
-
- RNA Interference and Gene Delivery 47
-
- Cancer Immunotherapy and Biomarkers 29
- Journals
- International Journal of Pharmaceutics (41 papers)Pharmaceutical Research (15 papers)Expert Opinion on Drug Delivery (14 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Yu Zhang
475 papers receiving 12.3k citations
Hit Papers
Peers
Comparison fields: 5 of 170
- Pharmaceutical Science 2.0k
- Biomaterials 3.4k
- Molecular Medicine 923
- Immunology 1.7k
- Biomedical Engineering 3.2k
Countries citing papers authored by Yu Zhang
This map shows the geographic impact of Yu Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Zhang more than expected).
Fields of papers citing papers by Yu Zhang
This network shows the impact of papers produced by Yu Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Zhang. The network helps show where Yu Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yu Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 19 | |
| 9 | 2023 | 6 | |
| 10 | 2023 | 13 | |
| 11 | 2023 | 18 | |
| 12 | 2023 | 0 | |
| 13 | 2023 | 7 | |
| 14 | 2023 | 19 | |
| 15 | 2023 | 4 | |
| 16 | 2023 | 1 | |
| 17 | 2022 | 32 | |
| 18 | Prognostic Significance and Therapeutic Target of CXC Chemokines in the Microenvironment of Lung Adenocarcinoma | 2022 | 7 |
| 19 | 2014 | 30 | |
| 20 | 2012 | 22 |
About Yu Zhang
Yu Zhang is a scholar working on Pharmaceutical Science, Biomaterials and Molecular Medicine, having authored 508 papers that have together received 12.5k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (119 papers), Advanced Drug Delivery Systems (80 papers), Nanoplatforms for cancer theranostics (72 papers), Drug Solubulity and Delivery Systems (69 papers), RNA Interference and Gene Delivery (47 papers), Immunotherapy and Immune Responses (46 papers), Cancer Immunotherapy and Biomarkers (29 papers) and Hydrogels: synthesis, properties, applications (21 papers). The work is most often cited by research in Pharmaceutical Science (2.0k citations), Biomaterials (3.4k citations) and Molecular Medicine (923 citations). Yu Zhang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xing Tang, Jingxin Gou, Tian Yin, Haibing He, Xing Tang, Haibing He, Lina Zhang, Bin Tian, Joseph D. Rosenblatt and Yifei Lü. Their work appears in journals such as International Journal of Pharmaceutics, Pharmaceutical Research, Expert Opinion on Drug Delivery, Molecular Pharmaceutics and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.